Anika Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
ANIK on Nasdaq
Location
32 Wiggins Avenue, Bedford, MA

There are no Buy or Sell transactions made by insiders since 12/22/2023

Anika Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cheryl R. Blanchard President, CEO, Director, Director $6.16M Mar 15, 2024
Michael L. Levitz EVP, CFO, Treasurer $1.76M Mar 15, 2024
David Colleran EVP, General Counsel, Corp Sec $1.35M Mar 15, 2024
Stephen D. Griffin EVP, CFO and Treasurer $993K Jun 3, 2024
Glenn R. Larsen Director $931K Jul 9, 2024
Susan Vogt Director $930K Jul 9, 2024
John B. Henneman III Director $921K Jul 9, 2024
Stephen Richard Director $869K Jul 9, 2024
Sheryl L. Conley Director $733K Jul 9, 2024
Gary P. Fischetti Director $708K Jul 9, 2024
Anne Nunes SVP, Chief Operations Officer $609K Oct 1, 2024
Thomas Finnerty EVP, Human Resources $590K Mar 9, 2022
Jeffery S. Thompson Director $588K Jun 14, 2023
William R. Jellison Director $231K Jul 9, 2024
Raymond J. Land Director $226K Jun 16, 2021
James Loerop EVP Business Development $182K Jul 8, 2021
Joseph H. Capper Director $161K Jul 9, 2024

Recent Insider Transactions by Companies or Individuals for Anika Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.